The healthcare regulator has reclassified diclofenac tablets, ending over-the-counter sales of the drug. The medicines and Healthcare products Regulatory Agency said it was associated with a “small but increased” risk of heart problems.
The change means patients using diclofenac will need a prescription from their doctor.
Dr Sarah Branch, the mHRA’s Vigilance and Risk management of medicines Deputy Director, said: “If patients have recently bought diclofenac tablets from their pharmacy and continue to need pain relief they should talk to their pharmacist about suitable alternative treatments.
“However there is no problem if they wish to stop taking diclofenac in the meantime.”
She added that those who have been prescribed diclofenac by a doctor should continue to take their medicine as instructed, as their medical history and any tests will already have been assessed.